Galveston, TX, United States of America

Oluwarotimi Folorunso

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: The University of Texas System. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Oluwarotimi Folorunso. Retrieved from https://idiyas.com/inventor/oluwarotimi-folorunso

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Oluwarotimi Folorunso

Introduction

Oluwarotimi Folorunso is an accomplished inventor based in Galveston, Texas. He has made significant contributions to the field of pharmaceuticals, particularly in the development of non-opioid pain relief solutions. His innovative approach aims to provide effective alternatives to traditional pain medications.

Latest Patents

Oluwarotimi holds a patent for a non-opioid anti-pain medication. This invention involves novel small molecules, referred to as Formula I, and their pharmaceutically acceptable salts. The primary focus of this patent is to inhibit FGF13-1b, which plays a crucial role in pain signaling pathways.

Career Highlights

Oluwarotimi is affiliated with the University of Texas System, where he continues to advance his research and development efforts. His work is characterized by a commitment to finding innovative solutions to pressing medical challenges.

Collaborations

Some of his notable coworkers include Fernanda Laezza and Jia Zhou. Their collaborative efforts contribute to the dynamic research environment at the University of Texas System.

Conclusion

Oluwarotimi Folorunso's contributions to the field of pain management through his innovative patent exemplify the potential of research in improving healthcare outcomes. His work continues to inspire advancements in non-opioid treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…